Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

China · Delayed Price · Currency is CNY

11.98

+0.08 (0.67%)

Feb 4, 2026, 3:00 PM CST

Revenue by Product

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Respiratory System Medication	1.45B
Respiratory System Medication Growth	11.89%
Tonic Medicine	378.50M
Tonic Medicine Growth	716.88%
Gynecological Medication	113.01M
Gynecological Medication Growth	46.05%
Orthopedic Medication	49.91M
Orthopedic Medication Growth	40.84%
Cardiovascular and Cerebrovascular Drugs	42.70M
Cardiovascular and Cerebrovascular Drugs Growth	3.31%
Other Business	547.55K
Other Business Growth	6.91%
Other	105.10M
Other Growth	387.64%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	2.14B
China Growth	31.16%